These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 6298516

  • 1. Different receptors mediate morphine-induced prolactin and growth hormone release.
    Spiegel K, Kourides IA, Pasternak GW.
    Life Sci; ; 31(20-21):2177-80. PubMed ID: 6298516
    [Abstract] [Full Text] [Related]

  • 2. Prolactin and growth hormone release by morphine in the rat: different receptor mechanisms.
    Spiegel K, Kourides IA, Pasternak GW.
    Science; 1982 Aug 20; 217(4561):745-7. PubMed ID: 6285470
    [Abstract] [Full Text] [Related]

  • 3. Differential role of the opioid mu and delta receptors in the activation of prolactin (PRL) and growth hormone (GH) secretion by morphine in the male rat.
    Koenig JI, Mayfield MA, McCann SM, Krulich L.
    Life Sci; 1984 May 07; 34(19):1829-37. PubMed ID: 6330479
    [Abstract] [Full Text] [Related]

  • 4. Naloxonazine actions in vivo.
    Ling GS, Simantov R, Clark JA, Pasternak GW.
    Eur J Pharmacol; 1986 Sep 23; 129(1-2):33-8. PubMed ID: 3021478
    [Abstract] [Full Text] [Related]

  • 5. Naloxazone, a long-acting opiate antagonist: effects on analgesia in intact animals and on opiate receptor binding in vitro.
    Pasternak GW, Childers SR, Snyder SH.
    J Pharmacol Exp Ther; 1980 Sep 23; 214(3):455-62. PubMed ID: 6105201
    [Abstract] [Full Text] [Related]

  • 6. Opiate analgesia: evidence for mediation by a subpopulation of opiate receptors.
    Pasternak GW, Childers SR, Snyder SH.
    Science; 1980 May 02; 208(4443):514-6. PubMed ID: 6245448
    [Abstract] [Full Text] [Related]

  • 7. Morphine catalepsy in the rat: involvement of mu 1 (high affinity) opioid binding sites.
    Ling GS, Pasternak GW.
    Neurosci Lett; 1982 Oct 08; 32(2):193-6. PubMed ID: 6292799
    [Abstract] [Full Text] [Related]

  • 8. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine.
    Krulich L, Koenig JI, Conway S, McCann SM, Mayfield MA.
    Neuroendocrinology; 1986 Oct 08; 42(1):75-81. PubMed ID: 3001565
    [Abstract] [Full Text] [Related]

  • 9. Naloxazone pretreatment modifies cardiorespiratory, temperature, and behavioral effects of morphine.
    Holaday JW, Pasternak GW, Faden AI.
    Neurosci Lett; 1983 Jun 16; 37(2):199-204. PubMed ID: 6308526
    [Abstract] [Full Text] [Related]

  • 10. Identification of multiple opiate receptors through neuroendocrine responses. II. Antagonism of mu, kappa and sigma agonists by naloxone and WIN 44,441-3.
    Pechnick R, George R, Poland RE.
    J Pharmacol Exp Ther; 1985 Jan 16; 232(1):170-7. PubMed ID: 2981314
    [Abstract] [Full Text] [Related]

  • 11. Differential development of acute tolerance to analgesia, respiratory depression, gastrointestinal transit and hormone release in a morphine infusion model.
    Ling GS, Paul D, Simantov R, Pasternak GW.
    Life Sci; 1989 Jan 16; 45(18):1627-36. PubMed ID: 2555641
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Naloxazone and pain-inhibitory systems: evidence for a collateral inhibition model.
    Kirchgessner AL, Bodnar RJ, Pasternak GW.
    Pharmacol Biochem Behav; 1982 Dec 16; 17(6):1175-9. PubMed ID: 7163350
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dissociation of morphine's analgesic and respiratory depressant actions.
    Ling GS, Spiegel K, Nishimura SL, Pasternak GW.
    Eur J Pharmacol; 1983 Jan 21; 86(3-4):487-8. PubMed ID: 6299765
    [No Abstract] [Full Text] [Related]

  • 17. The effects of chronic naloxone on pituitary hormone secretion in female rats.
    Gabriel SM, Simpkins JW, Millard WJ.
    Brain Res Bull; 1984 Apr 21; 12(4):359-62. PubMed ID: 6329481
    [Abstract] [Full Text] [Related]

  • 18. Increased analgesic potency of morphine and increased brain opioid binding sites in the rat following chronic naltrexone treatment.
    Yoburn BC, Goodman RR, Cohen AH, Pasternak GW, Inturrisi CE.
    Life Sci; 1985 Jun 17; 36(24):2325-32. PubMed ID: 2989632
    [Abstract] [Full Text] [Related]

  • 19. Naloxone does not reverse the inhibitory effect of morphine on luteinizing hormone secretion in prepubescent male rats.
    Cicero TJ, Nock B, O'Connor L.
    J Pharmacol Exp Ther; 1993 Jan 17; 264(1):47-53. PubMed ID: 8380870
    [Abstract] [Full Text] [Related]

  • 20. Neuroendocrine effects of dexmedetomidine: evidence of cross-tolerance between a mu-opioid agonist and an alpha 2-adrenoceptor agonist in growth hormone secretion of the male rat.
    Idänpään-Heikkilä JJ, Rauhala P, Männistö PT.
    Pharmacol Toxicol; 1996 Mar 17; 78(3):136-42. PubMed ID: 8882345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.